Non-Anticoagulant Uses of Heparin
Authors:
- David A. LaneDLDavid A. Lane
- Lewis AdamsLALewis Adams
- 8 July 1993
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 329 (2) , 129-130
Abstract
The clinical use of heparin as an anticoagulant and antithrombotic agent is established practice in prophylaxis against postoperative deep-vein thrombosis, in the initial treatment of overt deep-vein thrombosis, and in the prevention of thrombosis during extracorporeal circulation1. With its anticoagulant and antithrombotic action, heparin primarily binds to and accelerates the plasma inhibitor antithrombin III, and it has essential interactions with various coagulation proteinases. Furthermore, its interaction with other inhibitory proteins, such as heparin cofactor II and tissue-factor-pathway inhibitor, promotes additional proteinase inhibitory reactions24.Heparin is a highly sulfated, unbranched glycosaminoglycan present in the mast cells of most . . .Keywords
This publication has 4 references indexed in Scilit:
- Preventing Bronchoconstriction in Exercise-Induced Asthma with Inhaled HeparinNew England Journal of Medicine, 1993
- HeparinNew England Journal of Medicine, 1991
- Structure of Heparin and Heparin FragmentsAnnals of the New York Academy of Sciences, 1989
- INTRAPULMONARY HEPARIN A New Procedure for Anticoagulant TherapyThe Lancet, 1976